Taiwan's artificial intelligence medical imaging company Deep01 develops a brain medical imaging AI interpretation software, and has sent relevant medical material regulatory documents to the US FDA for review, becoming the first case in Taiwan. The software uses AI to automatically interpret whether the brain medical image is abnormal, and can be used to assist the hospital physician in diagnosis, improve the diagnostic accuracy and speed, improve the diagnosis process, and improve the medical quality of the patient.